135 related articles for article (PubMed ID: 11154232)
1. Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication.
Dummer R; Döbbeling U; Geertsen R; Willers J; Burg G; Pavlovic J
Blood; 2001 Jan; 97(2):523-7. PubMed ID: 11154232
[TBL] [Abstract][Full Text] [Related]
2. Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain).
Dummer R; Heald PW; Nestle FO; Ludwig E; Laine E; Hemmi S; Burg G
Blood; 1996 Aug; 88(4):1383-9. PubMed ID: 8695857
[TBL] [Abstract][Full Text] [Related]
3. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?
Sarris AH; Esgleyes-Ribot T; Crow M; Broxmeyer HE; Karasavvas N; Pugh W; Grossman D; Deisseroth A; Duvic M
Blood; 1995 Jul; 86(2):651-8. PubMed ID: 7605995
[TBL] [Abstract][Full Text] [Related]
4. Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1).
Dummer R; Geertsen R; Ludwig E; Niederer E; Burg G
Leuk Lymphoma; 1998 Feb; 28(5-6):515-22. PubMed ID: 9613981
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
[TBL] [Abstract][Full Text] [Related]
7. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
8. Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling.
Colamonici OR; Porterfield B; Domanski P; Constantinescu S; Pfeffer LM
J Biol Chem; 1994 Apr; 269(13):9598-602. PubMed ID: 8144546
[TBL] [Abstract][Full Text] [Related]
9. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
[TBL] [Abstract][Full Text] [Related]
10. The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.
Rook AH; Kubin M; Fox FE; Niu Z; Cassin M; Vowels BR; Gottleib SL; Vonderheid EC; Lessin SR; Trinchieri G
Ann N Y Acad Sci; 1996 Oct; 795():310-8. PubMed ID: 8958942
[TBL] [Abstract][Full Text] [Related]
11. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
12. [Current pathogenetic aspects of Sézary syndrome and mycosis fungoides].
Dummer R; Willers J; Döbbeling U; Burg G
Hautarzt; 2001 Mar; 52(3):189-92. PubMed ID: 11284062
[TBL] [Abstract][Full Text] [Related]
13. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
[TBL] [Abstract][Full Text] [Related]
14. Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons.
Kumar R; Tiwari RK; Kusari J; Sen GC
J Virol; 1987 Sep; 61(9):2727-32. PubMed ID: 2441075
[TBL] [Abstract][Full Text] [Related]
15. Establishment of new interferon-gamma-resistant mutant cells with dominant phenotypes.
Ohta T; Ando O; Kurimoto M
J Interferon Cytokine Res; 1995 Feb; 15(2):153-60. PubMed ID: 8590319
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors in interferon signaling.
David M
Pharmacol Ther; 1995 Feb; 65(2):149-61. PubMed ID: 7540766
[TBL] [Abstract][Full Text] [Related]
17. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
[TBL] [Abstract][Full Text] [Related]
18. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.
Showe LC; Fox FE; Williams D; Au K; Niu Z; Rook AH
J Immunol; 1999 Oct; 163(7):4073-9. PubMed ID: 10491012
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells.
Heinzerling L; Künzi V; Oberholzer PA; Kündig T; Naim H; Dummer R
Blood; 2005 Oct; 106(7):2287-94. PubMed ID: 15961518
[TBL] [Abstract][Full Text] [Related]
20. Down-modulation of responses to type I IFN upon T cell activation.
Dondi E; Rogge L; Lutfalla G; Uzé G; Pellegrini S
J Immunol; 2003 Jan; 170(2):749-56. PubMed ID: 12517937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
